Statistics for Cost utility analysis of long acting muscarinic antagonists (LAMAs) as an alternative to long acting beta agonists (labas) for treatment of severe COPD in the South African public sector
Total visits
| views | |
|---|---|
| Cost utility analysis of long acting muscarinic antagonists (LAMAs) as an alternative to long acting beta agonists (labas) for treatment of severe COPD in the South African public sector | 22 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 3 |
| July 2024 | 1 |
| August 2024 | 4 |
| September 2024 | 2 |
| October 2024 | 2 |
File Visits
| views | |
|---|---|
| MPH_COMH7175A_1946476_03.06.2023.pdf | 60 |
Top country views
| views | |
|---|---|
| South Africa | 21 |
| Norway | 1 |
Top city views
| views | |
|---|---|
| Johannesburg | 17 |
| Lenasia | 2 |
| Pretoria | 1 |